India Finalizes Compensation Formula For Clinical Trial-Related Deaths

Clinical Trials Advisor
Drug companies conducting clinical trials in India would be required to pay significant compensation for the deaths of some subjects during a study, under a rule released May 29 by the Central Drugs Standard Control Organization.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00